A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks
NCT03292640
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
547
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
DFD-03 (0.1% tazarotene) Lotion
DRUG:
DFD-03 (0% tazarotene) Lotion (Placebo)
Sponsor
Dr. Reddy's Laboratories Limited